ArQule Announces Collaboration With NIH For Clinical Development Of ARQ 092 In Proteus Syndrome
November 11, 2014 at 08:06 AM EST
ArQule, Inc. (NASDAQ: ARQL) today announced an agreement with the National Human Genome Research Institute (NHGRI) of the National ...